Semi‐Mechanism‐Based Population Pharmacokinetic Modeling of the Hedgehog Pathway Inhibitor Vismodegib

Vismodegib, approved for the treatment of advanced basal cell carcinoma, has shown unique pharmacokinetic (PK) nonlinearity and binding to α1‐acid glycoprotein (AAG) in humans. A semi‐mechanism‐based population pharmacokinetic (PopPK) model was developed from a meta‐dataset of 225 subjects enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, T, Wang, B, Gao, Y, Dresser, M, Graham, RA, Jin, JY
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716579/
https://www.ncbi.nlm.nih.gov/pubmed/26783504
http://dx.doi.org/10.1002/psp4.12039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716579/
https://www.ncbi.nlm.nih.gov/pubmed/26783504
http://dx.doi.org/10.1002/psp4.12039

Ejemplares similares